Healthcare

Commure Partners with DRH Health to Reduce Clinician Documentation Burden with MEDITECH-Integrated Ambient AI

DRH Health to Deploy AI to Streamline Clinical Workflows Across Its Care NetworkMOUNTAIN VIEW, Calif., Nov. 06, 2025 (GLOBE NEWSWIRE)…

2 months ago

Myriad Genetics to Highlight Genetic Testing Advancements at 2025 National Society of Genetic Counselors Annual Conference

SALT LAKE CITY, Nov. 06, 2025 (GLOBE NEWSWIRE) -- Myriad Genetics, Inc., (NASDAQ: MYGN), a leader in molecular diagnostic testing…

2 months ago

Biomerica Expands Contract Development and Manufacturing Services to Meet Growing Market Demand

Rising Demand from Third-Party Diagnostic and Biotechnology Companies Drives CDMO Service ExpansionComprehensive CDMO services now featured on Biomerica’s updated website…

2 months ago

IMUNON to Hold Third Quarter 2025 Financial Results and Business Update Conference Call on Thursday, November 13, 2025

LAWRENCEVILLE, N.J., Nov. 06, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (Nasdaq: IMNN), a clinical-stage company in Phase 3 development with…

2 months ago

Noom Unveils New Diabetes Lifestyle Program and Predictive Glucose Forecasting to Tackle America’s Diabetes Crisis

Innovative tools give employers, health plans, and individuals proactive ways to prevent and manage diabetes—one of the nation’s fastest-growing and…

2 months ago

Sangamo Therapeutics Reports Recent Business Highlights and Third Quarter 2025 Financial Results

Held meeting with U.S. Food and Drug Administration (FDA) where, among other things, they reiterated October 2024 agreement to use…

2 months ago

Solid Biosciences Awarded Innovation Passport Designation Under the New UK Innovative Licensing and Access Pathway for SGT-003, an Investigational Gene Therapy for Duchenne Muscular Dystrophy

- Innovation Passport award facilitates accelerated time to market and helps expedite patient access to transformative new medicines -  -…

2 months ago

Chemomab Announces Multiple Presentations at AASLD The Liver Meeting® 2025 Featuring Clinical Data from the Nebokitug Phase 2 Trial in Primary Sclerosing Cholangitis

— Phase 2 SPRING Trial Open Label Extension Showed Favorable Safety and Consistent Improvements in Key Biomarkers in PSC Patients…

2 months ago

Dentsply Sirona Reports Third Quarter 2025 Results

Dentsply Sirona Reports Third Quarter 2025 Results Net sales of $904 million decreased (5.0%) as-reported, decreased (8.0%) in constant currency…

2 months ago

Healthcare Minus the Headache: RokketMed, A Solution to Finding the Care That Counts

Turnkey San Francisco Platform Aims to Help All Employers and WorkersSAN FRANCISCO, Nov. 06, 2025 (GLOBE NEWSWIRE) -- In the…

2 months ago